# ChiRhoClin, Inc – FDA Inspection, Nov 3, 2022

Source: https://www.keypedia.com/records/fda_inspections/chirhoclin-inc/ec4ff8e9-44fa-4619-9428-b49c5b7f8c4b
Source feed: FDA_Inspections

> FDA inspection 1190730 of ChiRhoClin, Inc, November 03, 2022. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1190730
- Company Name: ChiRhoClin, Inc
- Inspection Date: 2022-11-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1282054 - 2025-09-15](https://www.keypedia.com/records/fda_inspections/chirhoclin-inc/e0fb5200-f0cd-48e1-b8f8-a761682704e7)
- [FDA Inspection 1011966 - 2017-05-30](https://www.keypedia.com/records/fda_inspections/chirhoclin-inc/a13098d9-f297-47e5-9353-81c2bd4b9f28)
- FDA Inspection 798256 - 2012-09-07
- [FDA Inspection 774375 - 2012-04-03](https://www.keypedia.com/records/fda_inspections/chirhoclin-inc/b01ffdf8-ca7d-479f-b2d1-1d42d0262220)
- FDA Inspection 585522 - 2009-05-26

Company: https://www.keypedia.com/companies/chirhoclin-inc/a63ad8fd-139c-40ea-bc63-d690e9b58437

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
